Greenwich Lifesciences Inc (GLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,414 | -7,749 | -5,080 | -2,473 | -8,892 |
| Depreciation Amortization | 4 | 3 | 2 | 1 | 4 |
| Accounts payable and accrued liabilities | 2,547 | 518 | 1,079 | 90 | 36 |
| Other Working Capital | 2,891 | 548 | 1,059 | 95 | 32 |
| Other Operating Activity | 4,707 | 1,265 | 110 | 504 | 2,343 |
| Operating Cash Flow | $-7,267 | $-5,414 | $-2,830 | $-1,783 | $-6,479 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,369 | 4,247 | 3,066 | 299 | N/A |
| Financing Cash Flow | $4,369 | $4,247 | $3,066 | $299 | $N/A |
| Beginning Cash Position | 6,989 | 6,989 | 6,989 | 6,989 | 13,468 |
| End Cash Position | 4,092 | 5,822 | 7,225 | 5,506 | 6,989 |
| Net Cash Flow | $-2,897 | $-1,167 | $236 | $-1,483 | $-6,479 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,267 | -5,414 | -2,830 | -1,783 | -6,479 |
| Free Cash Flow | -7,267 | -5,414 | -2,830 | -1,783 | -6,479 |